Moffitt Cancer Center Partners with Top Cancer Centers for Urgent Call to Get Cancer-Preventing HPV Vaccination Back on Track

The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.

Mutation Profile of Acral Nevi Differs from Acral Melanoma, Moffitt Researchers Say

BRAF V600E mutations are common in acral nevi

Moffitt Researchers Discover Regulatory Pathway That Blocks Immune Response Against Cancer

Preclinical study finds TIM-3 suppresses DNA uptake and STING signaling

Santosh Mohan Joins Moffitt Cancer Center as New Vice President of Digital

Santosh Mohan, MMCi, CPHIMS, FHIMSS has joined Moffitt Cancer Center as the new vice president of Digital.

Miles for Moffitt on Pace for In-Person Fundraiser Nov 20

Registration opens today: $25 for adults and $10 for children

Moffitt Investigators Identify STING Gene Methylation Allows Melanoma to Evade the Immune System

Findings lead to the development of therapeutic strategies to overcome it

Moffitt Cancer Center Hires New Vice President of Facilities and Support Services

Terrence Wright brings more than 30 years of facility management experience

Moffitt Researchers Demonstrate Tissue Architecture Regulates Tumor Evolution: Location Matters

Spatial constraints from the surrounding environment govern the evolution of tumors

U.S. Reps. Neal Dunn, Debbie Wasserman Schultz Honored with Moffitt Momentum Award

Their cancer advocacy includes lobbying for more research funding and improving access to care

Moffitt Researchers Use Mathematical Modeling to Analyze Dynamics of CAR T-Cell Therapy

Competition with normal T cells and random extinction events influence patient outcomes

Moffitt Cancer Center Advances Patient Standard of Care by Introducing Needleless Blood Draws

Moffitt is the first cancer center and the first hospital in Florida to use this new technology

Moffitt Cancer Center Takes Business of Biotech Conference Virtual

The two-day online event features keynote sessions with Drs. Patrick Hwu and John Cleveland

Moffitt Researchers Show Sequential Treatment with Immunotherapy and Targeted Therapy Prolongs Anti-Tumor Activity

Immunotherapy followed by BRAF and MEK inhibitors promotes anti-tumor immunity and suppresses signaling that leads to drug resistance

Lung Cancer Cells Have Differential Signaling Responses to KRAS Inhibitor Treatment with Important Implications for Emerging Clinical Trials

Moffitt researchers find epithelial and mesenchymal subtypes of lung cancer cells respond differently to KRASG12C inhibitor therapy

Moffitt Researchers Use Mathematical Modeling to Identify Factors that Determine Adaptive Therapy Success

Cell turnover and cost of resistance are important factors that impact adaptive therapy

News Releases